SynDRA canonical compound SYN0008012 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|---|
| Approval status | Approved · Rx/OTC |
| Primary target(s) | ATP4A |
| Mechanism of action | ATPase inhibitor |
| Indication | erosive esophagitis (EE) | gastroesophageal reflux disease (GERD) | gastroesophageal reflux disease (gerd), erosive esophagitis (ee), zollinger-ellison syndrome | Zollinger-Ellison syndrome |
| Disease area | gastroenterology |